Binding of ligands and activation of transcription by nuclear receptors

被引:172
作者
Steinmetz, ACU [1 ]
Renaud, JP [1 ]
Moras, D [1 ]
机构
[1] ULP, INSERM, CNRS,Lab Biol & Genom Struct, Inst Genet & Biol Mol & Cellulaire,UPR 9004, F-67404 Illkirch Graffenstaden, France
来源
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE | 2001年 / 30卷
关键词
mechanism of activation; isotype specificity; antagonism; partial agonism; conformational change;
D O I
10.1146/annurev.biophys.30.1.329
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear receptors (NRs) form a superfamily of ligand-inducible transcription factors composed of several domains. Recent structural studies focused on domain E, which harbors the ligand-binding site and the ligand-dependent transcription activation function AF-2. Structures of single representatives in an increasing number of various complexes as well as new structures of further NRs addressed issues such as discrimination of ligands, superagonism, isotype specificity, and partial agonism. Until today, one unique transcriptionally active form of domain E was determined; however, divergent tertiary structures of ape-forms and transcriptionally inactive forms are known. Thus, recent results link the transformation of NRs upon ligand binding to principles of protein folding. Furthermore, the ensemble of NR structures, including those of DNA-binding domains, provides one of the foundations for the understanding of interactions with transcription intermediary factors up to the characterization of the link between NR complexes and the basal transcriptional machinery at the structural level.
引用
收藏
页码:329 / 359
页数:35
相关论文
共 75 条
[1]   Disruption of retinoid-related orphan receptor β changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice [J].
André, E ;
Conquet, F ;
Steinmayr, M ;
Stratton, SC ;
Porciatti, V ;
Becker-André, M .
EMBO JOURNAL, 1998, 17 (14) :3867-3877
[2]   Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists [J].
Barkhem, T ;
Carlsson, B ;
Nilsson, Y ;
Enmark, E ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :105-112
[3]   Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2 [J].
Benecke, A ;
Chambon, P ;
Gronemeyer, H .
EMBO REPORTS, 2000, 1 (02) :151-157
[4]  
BILLAS IM, 2000, IN PRESS J BIOL CHEM
[5]   Retinoic acid receptor: A simulation analysis of retinoic acid binding and the resulting conformational changes [J].
Blondel, A ;
Renaud, JP ;
Fischer, S ;
Moras, D ;
Karplus, M .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 291 (01) :101-115
[6]   STRUCTURE-FUNCTION-RELATIONSHIPS IN THE VITAMIN-D ENDOCRINE SYSTEM [J].
BOUILLON, R ;
OKAMURA, WH ;
NORMAN, AW .
ENDOCRINE REVIEWS, 1995, 16 (02) :200-257
[7]   Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains [J].
Bourguet, W ;
Vivat, V ;
Wurtz, JM ;
Chambon, P ;
Gronemeyer, H ;
Moras, D .
MOLECULAR CELL, 2000, 5 (02) :289-298
[8]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[9]   Activation of estrogen receptor α by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7 [J].
Chen, DS ;
Riedl, T ;
Washbrook, E ;
Pace, PE ;
Coombes, RC ;
Egly, JM ;
Ali, S .
MOLECULAR CELL, 2000, 6 (01) :127-137
[10]   A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS [J].
CHEN, JD ;
EVANS, RM .
NATURE, 1995, 377 (6548) :454-457